healthbridge

A human bridge between the world of finance and #globalhealth. Innovative financing ideas, making health financing sustainable. #financialisation @GHC_IHEID

[healthbridge @NadyaNcw]

Thanks @LauraPiddock for your interest in our paper

Indeed financial analysis is a very useful methodology to understand just how tough it is for antibiotic SMEs

[Laura Piddock 💙 @LauraPiddock]

Excellent analysis of why new antibiotics don’t make it to patients. Plazomicin (Achaogen) financial post-mortem ⁦@JohnRex_NewAbx⁩ https://t.co/85PpNZWkG2

[healthbridge @NadyaNcw]

@GVAGrad_GHC adds our thanks to the witnesses who gave their memories to creating this valuable record of Emerging Financial Models for Antibiotic Development (2000-2016)
#AMR

[healthbridge @NadyaNcw]

Lessons from the past to inform the key discussions of the future of #AMR following todays HLM at #UNGA2024 #UNGA79

Take a look at the published Witness Seminar history of the #antibiotic pipeline from 2000 in our collaboration @GVAGrad_GHC with @EmptyPipeline

[healthbridge @NadyaNcw]

@AdrianATM90 @GVAGrad_GHC @SuerieMoon We will miss you. It has been a pleasure working with you. Thank you for all the insights, ideas, support and kindness. Madrid is lucky to have you back.

[healthbridge @NadyaNcw]

My appeal to make some noise and provide funding to combat #AMR in response to @WHO recently published AMR research priorities

@GVAGrad_GHC @GVAGrad @snsf_ch @unige_en @gardp_amr

[Medicus Mundi @Network_MMS]

Combatting the ‘Silent Pandemic’ of Antimicrobial Resistance: Break out the Pots and Pans Again 🥁🎺📣

📢An appeal by Nadya Wells, Geneva Graduate Institute (IHEID) @GVAGrad @GVAGrad_GHC

#OneHealth #AntimicrobialResistance #AMR #WAAW2023 #antibiotics

https://t.co/JaNLdBLfyF

[Dr Emma Hodcroft @firefoxx66]

One of the most important reasons why we shouldn't gatekeep access to science or data - anyone can do amazing things, create amazing resources, & contribute amazing insights - & we all benefit!

We never know what we don't know due to someone not being 'allowed' to try!

[healthbridge @NadyaNcw]

And A LOT more needs to be done for publishing pathways for interdisciplinary manuscripts @KurtDeketelaere big 🙏🏻 to Didier for his work on this agenda

[Laurie Garrett @Laurie_Garrett]

Just saying...

[𝙳𝚞𝚌-𝚀𝚞𝚊𝚗𝚐 𝙽𝚐𝚞𝚢𝚎𝚗 @duc_qn]

Autre conséquence du tarif inabordable des crèches, les femmes, le plus souvent, réduisent leur temps de travail à l’arrivée d’un enfant.

La Suisse est le pays de l’OCDE avec la plus faible proportion de parents travaillant tous les deux à plein temps

[healthbridge @NadyaNcw]

@nadinehillock i have written up this case study; would be very happy to discuss. Economic problems especially for SMEs often hidden behind complaints re novelty

[Nadine Hillock @nadinehillock]

Professor David Paterson using the example of plazomicin in his opening plenary to illustrate why the current funding model for antimicrobials is the reason why products fail @AusAntibiotics #antimicrobials2023 #antimicrobialResistance @CARB_X

[Laura Piddock 💙 @LauraPiddock]

Please RT 🙏🏻 Want to use your #medicinalchemistry knowledge in antibacterial discovery and exploratory research? If yes, please join us @gardp_amr 👇🏻based in UK, Germany, Spain or Switzerland @rsc_medchem https://t.co/h2a5dvOLKW

[healthbridge @NadyaNcw]

Amazing opportunity - do share in your networks

[Centre for Finance and Development @GVAGrad_CFD]

📢 Funded Ph.D. in financial economic history @GVAGrad

CFD is looking for an outstanding PhD student to assist the @snsf_ch project on the history of the Eurobond market, by @SussmanNathan, @JFloresZendejas, Rui Esteves & @alvarese06

➡️https://t.co/QmtHhYoALh

Share SVP!

[healthbridge @NadyaNcw]

Such a pleasure to have you with us, thanks for all your insights, looking forward to the next round in Oslo

[Global Health Centre @GVAGrad_GHC]

🗣Join us for our annual #WHA Briefing co-hosted with @unfoundation. We will focus on key issues being considered at #WHA75 & address the impact of #Covid19 on the Triple Billion Targets.

👉Register now to attend in person, or watch the live discussion on https://t.co/OtJI5GthLM

[healthbridge @NadyaNcw]

an honour to moderate this @gardp_amr panel #OneHealth approach to #AMR covering human and animal health, surveillance and diagnostics. Fantastic follow up article by @HealthPolicyW on outstanding science communication by @thvanboeckel

[Health Policy Watch @HealthPolicyW]

Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance | Report by @RFletch1979

@thvanboeckel @UNEP @andersen_inger
https://t.co/KikQh6mYs7

[healthbridge @NadyaNcw]

@kirchhelle that’s so cool!! I grew up in my mum’s micro lab @NHSBartsHealth school holidays were fun!!

[healthbridge @NadyaNcw]

@samiahurst @EckerleIsabella for you at Isabelle’s panel 😷😷😷

[Global Health Centre @GVAGrad_GHC]

📢@gardp_amr will host a session as part of the #GeneveHealthForum on May 3 with speakers from @WHO, @FINDdx, @thvanboeckel & @NadyaNcw on a #OneHealth approach to ensure appropriate and equitable access to #antibiotics.

👉Online & in-person registrations
https://t.co/BV5veeGKQ9

[healthbridge @NadyaNcw]

My message for #WorldHealthDay2022 #AMR needs urgent scientific, financial and policy innovation to create sustainable antibiotic markets🧯of medicine need funding

[Global Health Centre @GVAGrad_GHC]

🌍Ahead of #WorldHealthDay2022, @NadyaNcw, Senior Research Adviser @GHC_IHEID, highlights the health burden of #Antimicrobial resistance (#AMR), a future #Pandemic that could cause 10 million deaths per year.

👉Read article: https://t.co/pCGRpOvXim